DSIJ Mindshare

Outperforming stock to watch out for: Morepen Laboratories carves out its medical devices business into a subsidiary!

The stock is seen outperforming the broader market indices as it is up by more than 2.5 per cent.

Karan Dsij 0 3478 Article rating: 3.4

The Indian POC market is expected to touch US$ 16 billion by 2025 and we want to be the no. 1 POC player in India with a very large part of our manufacturing being ‘Made in India’.”

RSS
First26562657265826592661266326642665Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR